Concepedia

Publication | Open Access

Donanemab in Early Symptomatic Alzheimer Disease

2.2K

Citations

24

References

2023

Year

Abstract

ClinicalTrials.gov Identifier: NCT04437511.

References

YearCitations

Page 1